Disposition of perfluorobutane in rats after intravenous injection of Sonazoid™

Ultrasound in Medicine and Biology

Volumn 32, Issue 1, 2006, Pages 107-114

  Toft, Kim Gunnar ^a,b   Hustvedt, Svein Olaf ^a   Hals, Petter Arnt ^a   Oulie, Inger ^a   Uran, Steinar ^a   Landmark, Kristin ^a   Normann, Per Trygve ^a   Skotland, Tore ^a  

^a GE Healthcare   (United States)

^b BIACORE AB   (Sweden)

Author keywords

Contrast agent; Disposition; Exhalation; Perfluorobutane; Pharmacokinetics; Rats; Sonazoid ; Ultrasound

Indexed keywords

BLOOD VESSELS; BRAIN; CONTRAST MEDIA; GAS CHROMATOGRAPHY; MASS SPECTROMETRY; MEDICAL APPLICATIONS; MEDICAL IMAGING; PHARMACOKINETICS; ULTRASONICS;

CONTRAST AGENT; DISPOSITION; EXHALATION; PERFLUOROBUTANE;

FLUORINE COMPOUNDS;

FLUOROCARBON; NC 100100; PERFLUOROBUTANE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD; BODY FAT; BODY WEIGHT; BRAIN; CONTROLLED STUDY; DOSE RESPONSE; DRUG UPTAKE; ECHOGRAPHY; FEMALE; GAS CHROMATOGRAPHY; HEART; KIDNEY; LIVER; LUNG; MALE; MASS SPECTROMETRY; MUSCLE; NONHUMAN; PRIORITY JOURNAL; RAT; SAMPLING; SEX DIFFERENCE; SPLEEN; VALIDATION PROCESS;

ANIMALS; BREATH TESTS; CONTRAST MEDIA; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FERRIC COMPOUNDS; FLUOROCARBONS; INJECTIONS, INTRAVENOUS; IRON; MALE; MICROBUBBLES; OXIDES; RATS; RATS, SPRAGUE-DAWLEY; TISSUE DISTRIBUTION;

EID: 29144489064     PISSN: 03015629     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ultrasmedbio.2005.09.008     Document Type: Article

References (20)

1. S. Chang, E. Ozmert, N.J. Zimmermann Intraoperative perfluorocarbon liquids in the management of proliferative vitreoretinopathy Am J Ophthalmol 106 1988 668 674
2. J.W. Clayton Fluorocarbon toxicity and biological action Fluorine Chem Rev 1 1967 197 252
3. J.-M. Correas, A.R. Meuter, E. Singlas Human pharmacokinetics of a perfluorocarbon ultrasound contrast agent evaluated with gas chromatography Ultrasound Med Biol 27 2001 565 570
4. F. Forsberg, C.W. Piccoli, J.-B. Liu Hepatic tumor detection MR imaging and conventional US versus pulse-inversion harmonic US of NC100100 during its reticuloendothelial system-specific phase Radiology 222 2002 824 829
5. J.C. Hutter, H.M.-D. Luu, P.M. Mehlhaff, A.L. Killam, H.C. Dittrich Physiologically based pharmacokinetic model for fluorocarbon elimination after the administration of an octafluoropropane-albumin microsphere sonographic contrast agent J Ultrasound Med 18 1999 1 11
6. E. Hvattum, P.T. Normann, I. Oulie Determination of perfluorobutane in rat blood by automatic headspace gas chromatography and selected ion monitoring mass spectrometry J Pharm Biomed Anal 24 2001 487 494
7. G.M. Kindberg, H. Tolleshaug, N. Roos, T. Skotland Hepatic clearance of Sonazoid™ perfluorobutane microbubbles by Kupffer cells does not reduce the ability of liver to phagocytose or degrade albumin microspheres Cell Tissue Res 312 2003 49 54
8. 125I-labeled albumin in rats and whole blood and exhaled elimination kinetics of octafluoropropane in anesthetized canines, following intravenous administration of OPTISON® (FS069) Int J Toxicol 18 1999 49 63
9. W. Lepper, G.T. Sieswerda, J.L. Vanoverschelde Predictive value of markers of myocardial reperfusion in acute myocardial infarction for follow-up left ventricular function Am J Cardiol 88 2001 1358 1363
10. T. Li, K. Tachibana, M. Kuroki, M. Kuroki Gene transfer with echo-enhanced contrast agents Comparison between Albunex, Optison, and Levovist in mice - Initial results Radiology 229 2003 423 428
11. J.R. Lindner, S. Kaul Delivery of drugs with ultrasound Echocardiography 18 2001 329 337
12. C. Marelli Preliminary experience with NC100100, a new ultrasound contrast agent for intravenous injection Eur Radiol 9 Suppl. 3 1999 S343 S346
13. B.E. Marshall, D.E. Longnecker General anaesthetics J.G. Hardman L.E. Limbird P.B. Molinoff R.W. Ruddon A.G. Gilman Goodman & Gilman's The pharmacological basis of therapeutics. 1996 McGraw-Hill New York 303 330
14. T.R. Porter, F. Xie Therapeutic ultrasound for gene delivery Echocardiography 18 2001 349 353
15. R.V. Shohet, S. Chen, Y.-T. Zhou Echocardiographic destruction of albumin microbubbles directs gene delivery to the myocardium Circulation 101 2000 2554 2556
16. P.C. Sontum, J. Østensen, K. Dyrstad, L. Hoff Acoustic properties of NC100100 and their relation with the microbubble size distribution Invest Radiol 34 1999 268 275
17. K. Tachibana, S. Tachibana The use of ultrasound for drug delivery Echocardiography 18 2001 323 328
18. E.C. Unger, E. Hersh, M. Vannan, T. McCreery Gene delivery using ultrasound contrast agents Echocardiography 18 2001 355 361
19. S. Uran, K. Landmark, P. Normann A respiration-metabolism chamber system and a GC-MS method developed for studying exhalation of perfluorobutane in rats after intravenous injection of the ultrasound contrast agent Sonazoid™ J Pharm Biomed Anal 39 2005 746 751
20. P.K. Weathersby, L.D. Homer Solubility of inert gases in biological fluids and tissues A review Undersea Biomed Res 7 1980 277 296